MAIA Biotechnology
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -4,317 | 457 | -5,166 | -5,425 |
EBIT | -24,250,191 | -8,903 | -10,332 | -10,850 |
Net Income | -3,628 | -8,903 | -5,346 | -4,517 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,832,773 | -3,486 | -4,135 | -4,202 |
Cash | 8,658,031 | 10,891 | 10,144 | 10,863 |
Basic Shares | 32,115 | 33,202 | 30,300 | 27,697 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -24,269 | -23,254 | -19,766 | -15,762 |
EBIT | -23,254 | -20,182 | -16,176 | |
Net Income | -22,396 | -23,254 | -19,772 | -15,769 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,844,598 | -15,704 | -13,071 | -12,096 |
Cash | 8,658,031 | 9,601 | 7,150 | 10,950 |
Basic Shares | 32,115 | 22,197 | 13,262 | 9,277 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.13 |
2025-09-30 | -$0.27 |
2025-06-30 | -$0.18 |